Michael Yi Bonner

Publications
Public outreach and news

Articles

Article: ANTIOXIDANTS. 2021;11(1):12
Glycan Activation of Clec4b Induces Reactive Oxygen Species Protecting against Neutrophilia and Arthritis
Aoun M; Cai X; Xu B; Lahore GF; Bonner MY; He Y; Backdahl L; Holmdahl R
Article: JOURNAL OF SURGICAL RESEARCH. 2021;264:544-552
An Optimized Model of Hypertrophic Preconditioning Confers Cardioprotection in the Mouse
Cai X; Tian Y; Wu Y; Bonner MY; Zhuo X; Yuan Z
Article: NATURE COMMUNICATIONS. 2021;12(1):610
Endophilin A2 deficiency protects rodents from autoimmune arthritis by modulating T cell activation
Norin U; Rintisch C; Meng L; Forster F; Ekman D; Tuncel J; Klocke K; Backlund J; Yang M; Bonner MY; Lahore GF; James J; Shchetynsky K; Bergquist M; Gjertsson I; Hubner N; Backdahl L; Holmdahl R
Journal article: JOURNAL OF IMMUNOLOGY. 2020;204(1_Supplement):242.46
Formyl peptide receptor (FPR) agonists promote immune evasion independent of functional Ncf1 derived ROS
Bonner MY; Olofsson P; Holmdahl R
Article: CANCERS. 2020;12(2):E395-395
Establishment of a Temperature-Sensitive Model of Oncogene-Induced Senescence in Angiosarcoma Cells
da Costa A; Bonner MY; Rao S; Gilbert L; Sasaki M; Elsey J; MacKelfresh J; Arbiser JL
Article: ONCOTARGET. 2019;10(43):4424-4436
Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo.
Musi E; Schwartz GK; Yoo JH; Odelberg SJ; Li DY; Bonner MY; Selvakumar P; Rao S; Gilbert LC; Elsey J; Arbiser JL
Article: ONCOGENE. 2017;36(41):5709-5721
Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3
Sengupta S; Nagalingam A; Muniraj N; Bonner MY; Mistriotis P; Afthinos A; Kuppusamy P; Lanoue D; Cho S; Korangath P; Shriver M; Begum A; Merino VF; Huang C-Y; Arbiser JL; Matsui W; Gyorffy B; Konstantopoulos K; Sukumar S; Marignani PA; Saxena NK; Sharma D
Article: SCIENTIFIC REPORTS. 2017;7(1):11198
Evidence for biochemical barrier restoration: Topical solenopsin analogs improve inflammation and acanthosis in the KC-Tie2 mouse model of psoriasis
Arbiser JL; Nowak R; Michaels K; Skabytska Y; Biedermann T; Lewis MJ; Bonner MY; Rao S; Gilbert LC; Yusuf N; Karlsson I; Fritz Y; Ward NL
Article: CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2017;42(6):645-647
Comprehensive profiling of H-Ras signalling in angiosarcoma endothelium
da Costa A; Bonner M; Arbiser JL
Article: INTERNATIONAL JOURNAL OF DERMATOLOGY. 2017;56(7):754-761
Honokiol protects skin cells against inflammation, collagenolysis, apoptosis, and senescence caused by cigarette smoke damage
Costa A; Facchini G; Pinheiro ALTA; da Silva MS; Bonner MY; Arbiser J; Eberlin S
Article: ONCOTARGET. 2016;7(43):69321-69336
SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis
Akamata K; Wei J; Bhattacharyya M; Cheresh P; Bonner MY; Arbiser JL; Raparia K; Gupta MP; Kamp DW; Varga J
Article: ONCOTARGET. 2016;7(32):51651-51664
Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia
Laidlaw KME; Berhan S; Liu S; Silvestri G; Holyoake TL; Frank DA; Aggarwal B; Bonner MY; Perrotti D; Jorgensen HG; Arbiser JL
Article: ONCOTARGET. 2016;7(32):51569-51580
Tris DBA palladium is highly effective against growth and metastasis of pancreatic cancer in an orthotopic model
Diaz B; Ostapoff KT; Toombs JE; Lo J; Bonner MY; Curatolo A; Adsay V; Brekken RA; Arbiser JL
Article: MOLECULES. 2016;21(8):E995-995
Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies
Medra A; Witkowska M; Majchrzak A; Cebula-Obrzut B; Bonner MY; Robak T; Arbiser JL; Smolewski P
Article: EXPERIMENTAL DERMATOLOGY. 2016;25(6):479-480
Tuberculosis verrucosa cutis lesions exhibit a greater microvessel count than lupus vulgaris lesions
Bhandarkar SS; Lanka P; Lanka LR; Veledar E; Bonner MY; MacKelfresh J; Arbiser JL
Article: ONCOTARGET. 2016;7(11):12857-12868
Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo
Bonner MY; Karlsson I; Rodolfo M; Arnold RS; Vergani E; Arbiser JL
Article: ONCOTARGET. 2015;6(30):29947-29962
Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer
Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Article: ONCOTARGET. 2015;6(18):16396-16410
Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner
Avtanski DB; Nagalingam A; Kuppusamy P; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Article: NATURE COMMUNICATIONS. 2015;6:6656
Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3
Pillai VB; Samant S; Sundaresan NR; Raghuraman H; Kim G; Bonner MY; Arbiser JL; Walker DI; Jones DP; Gius D; Gupta MP
Article: RADIATION RESEARCH. 2015;183(3):262-270
Inactivation of NADPH Oxidases NOX4 and NOX5 Protects Human Primary Fibroblasts from Ionizing Radiation-Induced DNA Damage
Weyemi U; Redon CE; Aziz T; Choudhuri R; Maeda D; Parekh PR; Bonner MY; Arbiser JL; Bonner WM
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2015;112(7):2121-2126
NADPH oxidase 4 is a critical mediator in Ataxia telangiectasia disease
Weyemi U; Redon CE; Aziz T; Choudhuri R; Maeda D; Parekh PR; Bonner MY; Arbiser JL; Bonner WM
Article: VASCULAR CELL. 2015;7:5
Solenopsin A and analogs exhibit ceramide-like biological activity.
Karlsson I; Zhou X; Thomas R; Smith AT; Bonner MY; Bakshi P; Banga AK; Bowen JP; Qabaja G; Ford SL; Ballard MD; Petersen KS; Li X; Chen G; Ogretmen B; Zhang J; Watkins EB; Arnold RS; Arbiser JL
Article: MOLECULAR ONCOLOGY. 2014;8(3):565-580
Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis
Autanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Article: PROSTATE. 2014;74(4):408-420
Honokiol InhibitsAndrogen ReceptorActivity in Prostate Cancer Cells
Hahm E-R; Karlsson AI; Bonner MY; Arbiser JL; Singh SV
Article: PLOS ONE. 2014;9(2):e86369
Honokiol Enhances Paclitaxel Efficacy in Multi-Drug Resistant Human Cancer Model through the Induction of Apoptosis
Wang X; Beitler JJ; Wang H; Lee MJ; Huang W; Koenig L; Nannapaneni S; Amin ARMR; Bonner M; Shin HJC; Chen ZG; Arbiser JL; Shin DM
Article: BRITISH JOURNAL OF CANCER. 2013;109(2):433-443
Inducing apoptosis of cancer cells using small-molecule plant compounds that bind to GRP78
Martin S; Lamb HK; Brady C; Lefkove B; Bonner MY; Thompson P; Lovat PE; Arbiser JL; Hawkins AR; Redfern CPF
Article: CELL CYCLE. 2013;12(14):2200-2209
Identifying new small molecule anti-invasive compounds for glioma treatment
Munson J; Bonner M; Fried L; Hofmekler J; Arbiser J; Bellamkonda R
Article: VASCULAR CELL. 2012;4(1):11
Cooperative benefit for the combination of rapamycin and imatinib in tuberous sclerosis complex neoplasia.
Govindarajan B; Willoughby L; Band H; Curatolo AS; Veledar E; Chen S; Bonner MY; Abel M-G; Moses MA; Arbiser JL
Article: SCIENCE TRANSLATIONAL MEDICINE. 2012;4(127):127ra36
Anti-Invasive Adjuvant Therapy with Imipramine Blue Enhances Chemotherapeutic Efficacy Against Glioma
Munson JM; Fried L; Rowson SA; Bonner MY; Karumbaiah L; Diaz B; Courtneidge SA; Knaus UG; Brat DJ; Arbiser JL; Bellamkonda RV
Article: BREAST CANCER RESEARCH. 2012;14(1):R35
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Article: JOURNAL OF UROLOGY. 2012;187(1):296-301
Posterior Lumbar Vein Off the Retrohepatic Inferior Vena Cava: A Novel Anatomical Variant With Surgical Implications
Abbasi A; Johnson TV; Kleris R; Ying K; Bonner MY; Maithel SK; Kooby DA; Marshall FF; Master VA
Article: JOURNAL OF CLINICAL INVESTIGATION. 2009;119(8):2359-2365
Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice
Bhandarkar SS; Jaconi M; Fried LE; Bonner MY; Lefkove B; Govindarajan B; Perry BN; Parhar R; Mackelfresh J; Sohn A; Stouffs M; Knaus U; Yancopoulos G; Reiss Y; Benest AV; Augustin HG; Arbiser JL
Show more

All other publications

Corrigendum: CANCERS. 2021;13(9):2015
Establishment of a Temperature-Sensitive Model of Oncogene-Induced Senescence in Angiosarcoma Cells (vol 12, 395, 2020)
da Costa A; Bonner MY; Rao S; Gilbert L; Sasaki M; Elsey J; MacKelfresh J; Arbiser JL
Conference publication: JOURNAL OF IMMUNOLOGY. 2020;204(1)
Formyl peptide receptor (FPR) agonists promote immune evasion independent of functional Ncf1 derived ROS
Bonner MY; Olofsson P; Holmdahl R
Conference publication: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2020;140(7):S114
Establishment of a model of ras oncogene induced senescence in endothelial cells
Costa A; Teichmann M; Bonner M; Mackelfresh J; Gilbert L; Rao S; Arbiser J
Published conference paper: BIOCHIMICA ET BIOPHYSICA ACTA - GENERAL SUBJECTS. 2018;1862(11):2518-2527
Selenium unmasks protective iron armor: A possible defense against cutaneous inflammation and cancer
Arbiser JL; Bonner MY; Ward N; Elsey J; Rao S
Letter: JAMA DERMATOLOGY. 2017;153(9):931-932
Activation of Protein Kinase C ε in Merkel Cell Polyomavirus-Induced Merkel Cell Carcinoma
Costa A; Mackelfresh J; Gilbert L; Bonner MY; Arbiser JL
Conference publication: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2017;137(5):S18
Blockade of hippo pathway effector YAP1 with shRNA attenuates vascular development in Hemangioma Bend3 cells in vivo
Bonner M; Pankove R; Rao S; Costa A; Shetata B; Elsey J; Arbiser JL
Corrigendum: BREAST CANCER RESEARCH. 2017;19(1):39
Erratum to: Honokiol activates AMP-activated protein kinase in breast cancer cells via LKB1-dependent pathway and inhibits breast carcinogenesis (vol 14, pg R35, 2012)
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Review: NPJ PRECISION ONCOLOGY. 2017;1:23
Targeting the duality of cancer
Arbiser JL; Bonner MY; Gilbert LC
Review: AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2016;17(4):369-385
Use of Polyphenolic Compounds in Dermatologic Oncology
Costa A; Bonner MY; Arbiser JL
Meeting abstract: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2016;136(5):S19
A novel system to study the signaling of oncogene-induced senescence
da Costa A; Govindarajan B; Bonner MY; Rao S; Arbiser J
Editorial comment: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2016;136(3):561-564
Too Much, Too Little or Just Enough: A Goldilocks Effect for IL-13 and Skin Barrier Regulation?
Strid J; McLean WHI; Irvine AD
Editorial comment: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2016;136(3):564-566
Seborrheic Keratoses: The Rodney Dangerfield of Skin lesions, and Why They Should Get Our Respect
Arbiser JL; Bonner MY
Conference publication: JOURNAL OF AMERICAN ACADEMY OF DERMATOLOGY. 2016;74(5):AB27
Honokiol protects against cigarette smoke-induced collagen downregulation
Costa A; Clerici SP; Facchini G; Pinheiro A; Bonner MY; Arbiser J; Eberlin S
Conference publication: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2015;135:S85
Topical solenopsin analogs improve inflammation and acanthosis in the KC-Tie2 mouse model of psoriasis
Arbiser JL; Michaels KA; Nowak RS; Bonner M; Karlsson I; Fritz Y; Ward NL
Conference publication: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2015;135:S31
Angiogenesis in lupus vulgaris and tuberculosis verrucosa cutis lesions of cutaneous tuberculosis
Bhandarkar S; Lanka P; Lanka LR; Bonner M; Mackelfresh J; Arbiser JL
Meeting abstract: CANCER RESEARCH. 2014;74(19):lb-61-lb-61
Inhibiting "Dedifferentiation" in breast cancer cells using Honokiol - a plant derived polyphenol
Sengupta S; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Meeting abstract: CANCER RESEARCH. 2014;74(19):lb-187-lb-187
Novel mechanistic insights into the bioactive compound honokiol-mediated inhibition of epithelial to mesenchymal transition in breast cancer: Therapeutic modulation of miR-34a via tumor suppressor LKB1
Avtanski DB; Bonner MY; Tiutan TP; Arbiser JL; Saxena NK; Sharma D
Conference publication: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2014;134:S125
Honokiol Bis-Dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo
Bonner M; Karlsson I; Rodolfo M; Arnold RS; Vergani E; Arbiser J
Review: FUTURE MEDICINAL CHEMISTRY. 2014;6(12):1413-1422
The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer
Bonner MY; Arbiser JL
Letter: JAMA DERMATOLOGY. 2013;149(8):991-992
In Vivo GramStaining of Tinea Versicolor
Spence-Shishido A; Carr C; Bonner MY; Arbiser JL
Conference publication: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2013;133:S252
Novel synthesis and sctivity of solenopsin A and analogs, topical inhibitors of phosphoinositol-3 kinase/akt with ceramide-like properties
Karlsson I; Bonner MY; Zhou X; Zhang J; Watkins EB; Bowen JP; Arbiser JL
Letter: JOURNAL OF AMERICAN ACADEMY OF DERMATOLOGY. 2012;67(2):e81-e83
Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases
Arbiser JL; Bips M; Seidler A; Bonner MY; Kovach C
Review: CELLULAR AND MOLECULAR LIFE SCIENCES. 2012;69(14):2435-2442
Targeting NADPH oxidases for the treatment of cancer and inflammation
Bonner MY; Arbiser JL
Meeting abstract: CANCER RESEARCH. 2012;72:153
Honokiol, a promising small molecular weight natural agent, activates AMP-activated protein kinase in breast cancer cells via LKB1-dependent pathway and inhibits breast carcinogenesis
Nagalingam A; Arbiser JL; Bonner MY; Saxena N; Sharma D
Conference publication: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2012;132:S26
Evidence for a napdh oxidase-stat5 pathway in human melanoma
Arbiser JL; Bonner MY; Cerulli R; Liu S; Frank DA
Conference publication: JOURNAL OF UROLOGY. 2011;185(4):E708-E709
POSTERIOR LUMBAR VEIN OFF THE RETROHEPATIC INFERIOR VENA CAVA: A NOVEL ANATOMICAL VARIANT WITH SURGICAL IMPLICATIONS
Abbasi A; Johnson T; Kleris R; Ying K; Bonner M; Maithel S; Kooby D; Master V
Conference publication: BLOOD. 2011;118(21):723
Pro-Apoptotic Activity of Honokiol Analogues in B-Cell Lymphoid Malignancies
Smolewski P; Jeske A; Majchrzak A; Cebula B; Bonner MY; Arbiser JL; Robak T
Conference publication: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2011;131:S16
Voriconazole treatment plus UVB irradiation causes malignant transformation of human HaCaT keratinocyes
Berrios RL; Martin-Garrido A; Bonner MY; Pollack BP; Arbiser JL
Letter: JOURNAL OF AMERICAN ACADEMY OF DERMATOLOGY. 2011;64(1):200-201
High level expression of angiopoietin-2 in human abscesses
Bartus C; Brown LF; Bonner MY; Arbiser JL
Conference publication: CANCER RESEARCH. 2010;70:3702
Novel nanoparticle-delivered compound, Imipramine Blue, halts glioma invasion by affecting actin dynamics
Munson JM; Bonner M; Karumbaiah L; Arbiser J; Bellamkonda R
Conference publication: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2010;130:S2
Wilms Tumor 1 (WT-1) overexpression causes malignant transformation of endothelial cells
Chua R; Souza L; McLemore A; Bonner MY; Cohen C; Arbsier JL
Review: CURRENT MOLECULAR MEDICINE. 2009;9(8):929-934
Hemangiomas, Angiosarcomas, and Vascular Malformations Represent the Signaling Abnormalities of Pathogenic Angiogenesis
Arbiser JL; Bonner MY; Berrios RL
Editorial comment: ARCHIVES OF DERMATOLOGY. 2009;145(5):587-588
Melanomas Reveal Their Nakedness Uncovered by Interferon Alfa
Arbiser JL; Bonner MY
Show more

Articles

All other publications

News from KI

Events from KI